Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 301

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Selective and Rapid Uptake of Adeno-Associated Virus Type 2 in Brain

Bartlett, Jeffrey S., Samulski, R. Jude, McCown, Thomas J.·1998·Human Gene Therapy

Abstract

Recombinant adeno-associated virus (AAV) vectors effectively transfer and express foreign genes in the brain. The transferred genes, however, are selectively expressed in neurons, and the cause of this specificity is not understood. To address this question, wild-type AAV-2 capsids were covalently labeled with the fluorophore, Cy3, and infused into the inferior colliculus or the hippocampus. Using antibodies to identify neurons (NeuN), astrocytes (GFAP), or oligodendrocytes (OX-42), clear neuron-specific uptake of the virus was observed as early as 6 min after the start of the infusion. By 30 min postinfusion, AAV particles were present in the nucleus of neurons, yet in both the inferior colliculus and hippocampus, a subset of neurons did not take up the virus particles. No AAV particles were found in astrocytes 1.5 min or 24 hr after virus infusion. Interestingly, 1 hr postinfusion, no AAV particles were found in microglia, yet by 24 hr postinfusion, a punctate pattern of AAV particles was found in microglia. To test whether virus uptake correlated with vector-transduced cells, an rAAV-CMV-GFP virus was infused. By 3 days postinfusion, GFP was localized to neuronal populations with no expression in astrocytes or microglia, similar to that of fluorescent virus uptake. These findings demonstrate that in brain, AAV particles rapidly bind and enter primarily neurons with a pattern similar to that of in vivo vector transduction. In addition, these studies indicate that viral binding and uptake, independent of promoter tropism, can explain the specificity of AAV brain transduction. Thus, this first description of AAV kinetic disposition in vivo should facilitate targeted application of this vector for human brain gene therapy. To investigate in vivo observations of selective neural gene expression after AAV infection, wild-type AAV-2 capsids were covalently labeled with a fluorophore and infused into the inferior colliculus or the hippocampus. Using antibodies to identify neurons, astrocytes, or oligodendrocytes, clear neuron-specific uptake of the virus was observed as early as 6 min after the start of the infusion, and by 30 min AAV particles were clearly present in the nucleus of neurons. In both the inferior colliculus and hippocampus, however, a subset of neurons did not take up the virus particles, and no AAV particles were found in astrocytes. Three days after AAV-CMV-GFP infusion, gene product was localized to neuronal populations similar to that of fluorescent virus uptake, but not in astrocytes or microglia. Thus, the binding and uptake of AAV provide a promoter-independent explanation for the observed in vivo neural tropism.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1089/hum.1998.9.8-1181

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 301

Metadata

Authors
Bartlett, J. S., Samulski, R. J., & McCown, T. J.
Venue
Human Gene Therapy
Published
1998-05-20
Volume
9
Issue
8
Pages
1181-1186
ISSN
  • 1043-0342 (ISSN-L)
  • 1557-7422
OpenAlex
W1972747973
Cited by
301
References
2
FWCI
10.62
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Selective and Rapid Uptake of Adeno-Associated Virus Type 2 in Brain. https://app.cochat.ai/papers/10.1089/hum.1998.9.8-1181
The paper
Bartlett, J. S., Samulski, R. J., & McCown, T. J. (1998). Selective and Rapid Uptake of Adeno-Associated Virus Type 2 in Brain. Human Gene Therapy. https://doi.org/10.1089/hum.1998.9.8-1181

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.